Drug
JNJ-64417184 clinical trials
Also written JNJ-64417184.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Development codes
- JNJ-64417184
- 6
Studies by the year they started
7 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
Who runs them
Industry 7 · Other 0
Janssen Research & Development, LLC (5) · Janssen BioPharma, Inc. (1) · Janssen Pharmaceutica N.V., Belgium (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses JNJ-64417184 is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04258189Written as JNJ-64417184
- A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04453189Written as JNJ-64417184
- A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04090086Written as JNJ-64417184
- A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT03952507Written as JNJ-64417184 600 (Oral Tablet Formulation)
- A Study to Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult ParticipantsTerminatedPhase 1Janssen Pharmaceutica N.V., BelgiumNCT04426357Written as JNJ-64417184
- A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy ParticipantsCompletedPhase 1Janssen BioPharma, Inc.NCT03403348Written as JNJ-64417184
- A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as TabletsCompletedPhase 1Janssen Research & Development, LLCNCT04121052Written as JNJ-64417184